News

TOPRA holds medical devices-focused Brexit roundtable

Posted on 24/05/2018
First TOPRA Brexit Roundtable on medical devices examines how the impact of the UK leaving the EU could be mitigated

Why Diversity Matters

Posted on 21/05/2018
On World Day for Cultural Diversity for Dialogue and Development 2018 (21 May), Aman Khera, a member of TOPRA’s Diversity Committee, explores diversity and inclusion in regulatory affairs as a driver for advancing healthcare.

Drug approvals in EU and US for SMEs exceed big pharma in 2017

Posted on 17/05/2018
Consulting group finds that SMEs made up 51% of new drug approvals in the EU an US in 2017, compared with 49% from big pharma.

CPD certificate for 2017 now available

Posted on 26/04/2018
TOPRA members can now download a certificate of their continuing professional development (CPD) activities in 2017.

First TOPRA members achieve chartered scientist status

Posted on 29/03/2018
TOPRA is delighted to announce that Lorna Griffin (Rapport Strategic Services Ltd) and Antonia Orsi (Salupont Consulting Ltd) are the first TOPRA members to achieve recognition as chartered scientists since we started offering this to members in Janu

TOPRA statement on UK Select Committee Brexit report

Posted on 22/03/2018
TOPRA lauds UK Government's Health and Social Care Committee for advice on continued alignment with EU regulatory regimes for medicines, medical devices and substances of human origin.

TOPRA delivers first training programme in Malta

Posted on 22/03/2018
TOPRA recently held its first training programme in Malta for regulatory professionals in collaboration with the Maltese Medicines Authority.

A message from TOPRA President Angela Stokes

Posted on 06/01/2018
We're expanding our efforts to help regulatory affairs professionals stay current in an ever-changing environment.

No content found

No content found

No content found

No content found

No content found